Representative Image
Delhi hospital achieves successful results on use of Monoclonal Antibody as day care therapy; patients discharged within 12 hours ANI | Updated: Jun 09, 2021 17:28 IST
New Delhi [India], June 9 (ANI): Sir Ganga Ram Hospital of New Delhi has reported successful use of Monoclonal antibody in two patients with fast progression of symptoms within the first seven days. Both patients recovered and were discharged with 12 hours.
As per the press release of the hospital, a 36-year-old healthcare worker with high-grade fever, cough, myalgia, severe weakness, and leucopenia was administered REGCov2 (CASIRIVIMAB Plus IMDEVIMAB) on day six of the disease. Patient s parameter improved within 12 hours and was discharged, the release stated.
UPDATED: June 9, 2021 18:36 IST
The coronavirus cases in India has been falling after the second wave reached its peak in May. (Photo: PTI)
Doctors at Sir Ganga Ram Hospital in New Delhi have successfully treated patients suffering from Covid-19 using monoclonal antibody therapy. The two patients who were administered the REGCov2, designed to produce resistance against the SARS-CoV-2, were discharged within 12 hours of being given the doses.
Monoclonal antibodies are identical copies of an antibody that targets one specific antigen. This treatment has previously been used in treating deadly pathogens like Ebola and HIV. The REGCov2 is developed by Regeneron which is conducting the phase-3 Covid-19 prevention trials.
Clinical parameters of two COVID-19 patients improved significantly within 12 hours of administering monoclonal antibody therapy, doctors at Sir Ganga Ram Hospital in Delhi said on Wednesday.
‘Could prove to be a game changer’
Sir Ganga Ram Hospital on Wednesday said that monoclonal antibody therapy was successfully used in two patients and one of the patient’s parameters improved within 12 hours and was discharged.
Pooja Khosla, senior consultant, Department of Medicine of the hospital said, “Monoclonal antibody could prove to be a game changer in times to come if used at an appropriate time. It can avoid hospitalisation in high-risk groups and progression to severe disease. It can help escaping or reducing the usage of steroids and immunomodulation which would further reduce the risk of fatal infections like mucormycosis, secondary bacterial and viral infections.”
Both patients recovered within 12 hours of the the therapy, the hospital said. File
New Delhi:
Sir Ganga Ram Hospital of New Delhi has reported successful use of Monoclonal antibody in two Covid patients with fast progression of symptoms within the first seven days. Both patients recovered and were discharged within 12 hours.
As per a press release of the hospital, a 36-year-old healthcare worker with high-grade fever, cough, myalgia, severe weakness, and leucopenia was administered REGCov2 (CASIRIVIMAB Plus IMDEVIMAB) on day six of the disease. Patient s parameter improved within 12 hours and was discharged, the release stated.
The second case was of the 80-year-old R K Razdan who was diabetic, hypertensive and had high-grade fever and cough.